Results 91 to 100 of about 9,833 (102)

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Journal of Hepatology, 2011
Mi Lucena, Marina Berenguer
exaly  

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Toxicology in Vitro, 2015
Simone Schadt, Stefan Kustermann, Stephen M Fowler   +2 more
exaly  

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

Frontiers in Pharmacology, 2019
Rolf Teschke
exaly  

The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury

Expert Review of Gastroenterology and Hepatology, 2018
Shraddha Thakkar, Minjun Chen, Hong Fang
exaly  

In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI

Journal of Pharmacokinetics and Pharmacodynamics, 2012
Alison Harrill, Melvin E Andersen
exaly  

Global Epidemiology of Drug-Induced Liver Injury (DILI)

Current Hepatology Reports, 2019
Einar S Björnsson
exaly  

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

Current Drug Metabolism, 2018
Lucija Kuna, Tomislav Kizivat, Kristina Bojanic   +2 more
exaly  

Latest advances in diagnosing and predicting DILI: what was new in 2017?

Expert Review of Gastroenterology and Hepatology, 2018
James H Lewis
exaly  

Current limitations and future opportunities for prediction of DILI from in vitro

Archives of Toxicology, 2016
Adrian B Roth
exaly  

Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

Clinical Gastroenterology and Hepatology, 2018
Inmaculada Medina-Caliz, Miren García Cortes, Andres Gonzalez-Jimenez   +2 more
exaly